undamentalytics Newsletter
Sign in

Lisata Therapeutics, Inc. balance sheet

At the end of fiscal 2025, Lisata Therapeutics, Inc. had total assets of $17.7m, total liabilities of $3.1m and shareholders' equity of $14.9m. It held $16.0m in cash against $0 of debt: net cash of $16.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1641446191973223161610
Receivables6112330—010—
Inventory21111————————
Total current assets473917513629257254351811
Goodwill271111112577—————
Total assets143155549012657547355351811
Accounts payable1423364232111
Deferred revenue (current)2112455—————
Total current liabilities3336101016212167633
Short-term debt———0143—————
Long-term debt—00014113—————
Total debt100031616800000
Total liabilities———2868343077633
Shareholders' equity4962336359245674830158
Non-controlling interests and other (assets − liabilities − equity)——————19————−0
Net debt (negative = net cash)−6−4−13−43−3−21−32−23−16−16−10
Shares outstanding64m109m16m27m37m6m——8m8m9m9m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IBIO vs LSTAAIM vs LSTACLDX vs LSTA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Lisata Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lisata Therapeutics, Inc.